NO20012128L - DDS-forbindelse og metode for måling av denne - Google Patents
DDS-forbindelse og metode for måling av denneInfo
- Publication number
- NO20012128L NO20012128L NO20012128A NO20012128A NO20012128L NO 20012128 L NO20012128 L NO 20012128L NO 20012128 A NO20012128 A NO 20012128A NO 20012128 A NO20012128 A NO 20012128A NO 20012128 L NO20012128 L NO 20012128L
- Authority
- NO
- Norway
- Prior art keywords
- measuring
- dds
- connection
- dds connection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31013098 | 1998-10-30 | ||
| JP32927298 | 1998-11-19 | ||
| PCT/JP1999/006016 WO2000025825A1 (en) | 1998-10-30 | 1999-10-29 | Dds compounds and method for assaying the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20012128D0 NO20012128D0 (no) | 2001-04-30 |
| NO20012128L true NO20012128L (no) | 2001-06-20 |
Family
ID=26566202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012128A NO20012128L (no) | 1998-10-30 | 2001-04-30 | DDS-forbindelse og metode for måling av denne |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6811996B1 (de) |
| EP (2) | EP1619210A1 (de) |
| KR (1) | KR20010090602A (de) |
| CN (2) | CN1191093C (de) |
| AU (1) | AU765409B2 (de) |
| BR (1) | BR9915198A (de) |
| CA (1) | CA2348931A1 (de) |
| EA (1) | EA003790B1 (de) |
| HK (1) | HK1042438A1 (de) |
| ID (1) | ID29943A (de) |
| IL (1) | IL142842A0 (de) |
| MX (1) | MXPA01004239A (de) |
| NO (1) | NO20012128L (de) |
| TW (1) | TWI232930B (de) |
| WO (1) | WO2000025825A1 (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW527183B (en) | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
| EA003398B1 (ru) * | 1998-05-22 | 2003-04-24 | Дайити Фармасьютикал Ко., Лтд. | Лекарственный комплекс c полимерным носителем |
| CN1191093C (zh) * | 1998-10-30 | 2005-03-02 | 第一制药株式会社 | Dds化合物及其测定方法 |
| US20030166513A1 (en) * | 2000-06-29 | 2003-09-04 | Akihiro Imura | Dds compound and process for the preparation thereof |
| WO2005110430A1 (en) * | 2004-05-10 | 2005-11-24 | Michigan State University | Method of use of carboxylated polysaccharides topically on the eyeball |
| US9820986B2 (en) * | 2005-03-04 | 2017-11-21 | Taiwan Hopaz Chems, Mfg. Co., Ltd. | Glycopeptide compositions |
| CA2625426A1 (en) * | 2005-09-22 | 2007-03-29 | Hadasit Medical Research Services & Development Limited | Dextran and arabinogalactan conjugates of therapeutically active compounds |
| CN1973902B (zh) * | 2006-12-12 | 2010-11-10 | 东北师范大学 | 以人参多糖为载体的抗肿瘤药物阿霉素复合物及制备方法 |
| US9895449B2 (en) | 2010-05-25 | 2018-02-20 | Syndevrx, Inc. | Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof |
| WO2011150022A2 (en) | 2010-05-25 | 2011-12-01 | Syndevrx, Inc. | Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof |
| TW201348244A (zh) * | 2012-05-23 | 2013-12-01 | Iner Aec Executive Yuan | 醣質藥物造影劑前驅物之合成方法 |
| ES2773710T3 (es) | 2012-10-11 | 2020-07-14 | Daiichi Sankyo Co Ltd | Enlazadores para conjugados de anticuerpo - fármaco |
| WO2014061277A1 (ja) | 2012-10-19 | 2014-04-24 | 第一三共株式会社 | 親水性構造を含むリンカーで結合させた抗体－薬物コンジュゲート |
| CA2908993C (en) | 2013-04-10 | 2023-05-23 | Syndevrx, Inc. | Metap2 inhibitors and methods of treating obesity |
| AU2014371934B2 (en) * | 2013-12-25 | 2020-01-23 | Daiichi Sankyo Company, Limited | Anti-TROP2 antibody-drug conjugate |
| IL310627B2 (en) | 2014-01-31 | 2026-04-01 | Daiichi Sankyo Co Ltd | Anti-HER2 antibody-drug conjugates, compositions containing them and uses thereof |
| KR102445502B1 (ko) | 2014-04-10 | 2022-09-21 | 다이이찌 산쿄 가부시키가이샤 | 항her3 항체-약물 콘주게이트 |
| EP3130608B1 (de) | 2014-04-10 | 2019-09-04 | Daiichi Sankyo Co., Ltd. | (anti-her2-antikörper)-arzneimittelkonjugat |
| CN116059395A (zh) | 2015-06-29 | 2023-05-05 | 第一三共株式会社 | 用于选择性制造抗体-药物缀合物的方法 |
| ES2893749T3 (es) | 2015-12-10 | 2022-02-10 | Syndevrx Inc | Derivados de fumagilol y polimorfos de los mismos |
| CA3239447A1 (en) | 2016-01-11 | 2017-07-20 | Syndevrx, Inc. | Treatment for tumors driven by metabolic dysfunction |
| CA3011946A1 (en) * | 2016-03-07 | 2017-09-14 | Arrowhead Pharmaceuticals, Inc. | Targeting ligands for therapeutic compounds |
| SG11201901841TA (en) | 2016-09-02 | 2019-03-28 | Arrowhead Pharmaceuticals Inc | Targeting ligands |
| KR20190066026A (ko) | 2016-10-07 | 2019-06-12 | 다이이찌 산쿄 가부시키가이샤 | 항 her2 항체-약물 콘주게이트 투여에 의한 내성암의 치료 |
| US11273155B2 (en) | 2016-12-12 | 2022-03-15 | Daiichi Sankyo Company, Limited | Combination of antibody-drug conjugate and immune checkpoint inhibitor |
| JP6679762B2 (ja) | 2017-01-17 | 2020-04-15 | 第一三共株式会社 | 抗ｇｐｒ２０抗体及び抗ｇｐｒ２０抗体−薬物コンジュゲート |
| TW202532104A (zh) | 2017-05-15 | 2025-08-16 | 日商第一三共股份有限公司 | 抗體－藥物結合物及其用途 |
| IL324591A (en) | 2017-08-31 | 2026-01-01 | Daiichi Sankyo Co Ltd | Improved antibody-drug conjugate production methods |
| CA3074208C (en) | 2017-08-31 | 2023-10-03 | Daiichi Sankyo Company, Limited | Novel method for producing antibody-drug conjugate |
| SG11202010496WA (en) | 2018-05-18 | 2020-12-30 | Daiichi Sankyo Co Ltd | Anti-muc1 antibody-drug conjugate |
| WO2020022475A1 (ja) | 2018-07-27 | 2020-01-30 | 第一三共株式会社 | 抗体－薬物コンジュゲートの薬物部位を認識する蛋白質 |
| CA3108044A1 (en) | 2018-07-31 | 2020-02-06 | Daiichi Sankyo Company, Limited | Treatment of metastatic brain tumor by administration of antibody-drug conjugate |
| JP2022512826A (ja) | 2018-10-26 | 2022-02-07 | シンデブルックス，インコーポレイティド | ＭｅｔＡＰ２阻害剤のバイオマーカーとその応用 |
| US11555019B2 (en) | 2019-07-10 | 2023-01-17 | Cybrexa 3, Inc. | Peptide conjugates of microtubule-targeting agents as therapeutics |
| MX2022000449A (es) | 2019-07-10 | 2022-04-25 | Cybrexa 2 Inc | Conjugados peptídicos de citotoxinas como terapéuticos. |
| CN118047886A (zh) * | 2022-11-17 | 2024-05-17 | 菲鹏生物股份有限公司 | 化合物及其制备方法和封闭剂 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4386026A (en) * | 1981-04-20 | 1983-05-31 | Merck & Co., Inc. | Cell-specific glycopeptide ligands |
| JP2791001B2 (ja) | 1990-02-16 | 1998-08-27 | 株式会社ディ・ディ・エス研究所 | グリコシル−蛋白誘導体 |
| JPH0784481B2 (ja) | 1991-02-21 | 1995-09-13 | 株式会社デイ・デイ・エス研究所 | カルボキシメチルマンノグルカン及びその誘導体 |
| JP2589431B2 (ja) | 1991-05-13 | 1997-03-12 | 株式会社ディ・ディ・エス研究所 | 糖修飾ポリグルタミン酸誘導体及びその製造法 |
| JP2774417B2 (ja) | 1991-08-07 | 1998-07-09 | 株式会社ディ・ディ・エス研究所 | ペプチド骨格を有する分枝鎖型糖複合体及び微粒子キャリヤー |
| JP2589435B2 (ja) | 1991-09-17 | 1997-03-12 | 株式会社ディ・ディ・エス研究所 | 糖修飾ポリリジン誘導体 |
| JP2774429B2 (ja) | 1992-03-17 | 1998-07-09 | 株式会社ディ・ディ・エス研究所 | 糖骨格を有する分枝鎖型誘導体 |
| JP3359955B2 (ja) * | 1992-07-16 | 2002-12-24 | 第一製薬株式会社 | 抗腫瘍剤 |
| ES2149867T3 (es) * | 1993-02-26 | 2000-11-16 | Drug Delivery System Inst Ltd | Derivados de polisacaridos y soportes para farmacos. |
| US6214345B1 (en) * | 1993-05-14 | 2001-04-10 | Bristol-Myers Squibb Co. | Lysosomal enzyme-cleavable antitumor drug conjugates |
| JPH0784481A (ja) | 1993-06-26 | 1995-03-31 | Ricoh Co Ltd | 画像形成装置 |
| GB2282384B8 (en) * | 1993-08-18 | 1997-09-04 | Europ Economic Community | Drug delivery agents incorporating mitomycin |
| JP3418693B2 (ja) | 1993-09-06 | 2003-06-23 | 敏宏 赤池 | ポリ−ε−置換−Ｌ−リジンのＤ−ガラクトピラノシル−グルコン酸誘導体 |
| JPH07228688A (ja) | 1994-02-18 | 1995-08-29 | Yamanouchi Pharmaceut Co Ltd | 糖修飾ポリ−ω−置換−Ｌ−グルタミン酸誘導体およびその製造方法 |
| US5658592A (en) | 1994-05-13 | 1997-08-19 | Kuraray Co., Ltd. | Medical crosslinked polymer gel of carboxylic polysaccharide and diaminoalkane |
| JP3001381B2 (ja) | 1994-09-16 | 2000-01-24 | 株式会社ディ・ディ・エス研究所 | 臓器移行性を有する多糖誘導体および薬物担体 |
| US5886143A (en) * | 1994-12-07 | 1999-03-23 | Neorx Corporation | Hepatic-directed compounds and reagents for preparation thereof |
| JP3053764B2 (ja) | 1995-03-17 | 2000-06-19 | 財団法人神奈川科学技術アカデミー | 糖鎖高分子及びそれを用いた細胞処理剤並びに処理方法 |
| US5714511A (en) * | 1995-07-31 | 1998-02-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs |
| CA2182851A1 (en) * | 1995-08-15 | 1997-02-16 | August Masaru Watanabe | Method for treating substance abuse withdrawal |
| TW527183B (en) * | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
| US6368598B1 (en) * | 1996-09-16 | 2002-04-09 | Jcrt Radiation Oncology Support Services, Inc. | Drug complex for treatment of metastatic prostate cancer |
| JP2001505194A (ja) * | 1996-11-05 | 2001-04-17 | ブリストル―マイヤーズ・スクイブ・カンパニー | 分枝ペプチド・リンカー |
| US6340461B1 (en) * | 1996-12-17 | 2002-01-22 | David Stephen Terman | Superantigen based methods and compositions for treatment of diseases |
| JP2002508758A (ja) * | 1997-06-12 | 2002-03-19 | エムエル・ラボラトリーズ・パブリック・リミテッド・カンパニー | 生物的に活性な材料 |
| EA003398B1 (ru) | 1998-05-22 | 2003-04-24 | Дайити Фармасьютикал Ко., Лтд. | Лекарственный комплекс c полимерным носителем |
| CN1191093C (zh) * | 1998-10-30 | 2005-03-02 | 第一制药株式会社 | Dds化合物及其测定方法 |
-
1999
- 1999-10-29 CN CNB998152889A patent/CN1191093C/zh not_active Expired - Fee Related
- 1999-10-29 BR BR9915198-7A patent/BR9915198A/pt not_active Application Discontinuation
- 1999-10-29 IL IL14284299A patent/IL142842A0/xx unknown
- 1999-10-29 AU AU64880/99A patent/AU765409B2/en not_active Ceased
- 1999-10-29 KR KR1020017005434A patent/KR20010090602A/ko not_active Ceased
- 1999-10-29 US US09/807,980 patent/US6811996B1/en not_active Expired - Fee Related
- 1999-10-29 EA EA200100485A patent/EA003790B1/ru not_active IP Right Cessation
- 1999-10-29 MX MXPA01004239A patent/MXPA01004239A/es unknown
- 1999-10-29 CA CA002348931A patent/CA2348931A1/en not_active Abandoned
- 1999-10-29 CN CN2004100115162A patent/CN1661044A/zh active Pending
- 1999-10-29 WO PCT/JP1999/006016 patent/WO2000025825A1/ja not_active Ceased
- 1999-10-29 EP EP05015058A patent/EP1619210A1/de not_active Withdrawn
- 1999-10-29 HK HK02104211.3A patent/HK1042438A1/zh unknown
- 1999-10-29 ID IDW00200101143A patent/ID29943A/id unknown
- 1999-10-29 EP EP99952805A patent/EP1155702A4/de not_active Ceased
- 1999-10-30 TW TW091113738A patent/TWI232930B/zh not_active IP Right Cessation
-
2001
- 2001-04-30 NO NO20012128A patent/NO20012128L/no not_active Application Discontinuation
-
2004
- 2004-04-13 US US10/822,661 patent/US7041818B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU765409B2 (en) | 2003-09-18 |
| KR20010090602A (ko) | 2001-10-18 |
| ID29943A (id) | 2001-10-25 |
| NO20012128D0 (no) | 2001-04-30 |
| CN1661044A (zh) | 2005-08-31 |
| EA003790B1 (ru) | 2003-10-30 |
| BR9915198A (pt) | 2001-08-14 |
| US6811996B1 (en) | 2004-11-02 |
| EP1619210A1 (de) | 2006-01-25 |
| CN1191093C (zh) | 2005-03-02 |
| AU6488099A (en) | 2000-05-22 |
| CA2348931A1 (en) | 2000-05-11 |
| US20040192644A1 (en) | 2004-09-30 |
| WO2000025825A1 (en) | 2000-05-11 |
| CN1332640A (zh) | 2002-01-23 |
| EP1155702A4 (de) | 2004-12-15 |
| IL142842A0 (en) | 2002-03-10 |
| HK1042438A1 (zh) | 2002-08-16 |
| MXPA01004239A (es) | 2002-06-04 |
| EP1155702A1 (de) | 2001-11-21 |
| TWI232930B (en) | 2005-05-21 |
| US7041818B2 (en) | 2006-05-09 |
| EA200100485A1 (ru) | 2001-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012128L (no) | DDS-forbindelse og metode for måling av denne | |
| NO992351D0 (no) | Pµl og fremgangsmÕte for installasjon av denne | |
| NO983366L (no) | FremgangsmÕte og anordning for bestemmelse av banen til borehull | |
| NO980605D0 (no) | Fremgangsmåter og anordning for komplettering av underjordisk brönn | |
| NO980604D0 (no) | Fremgangsmåte og anordning for komplettering av en underjordisk brönn | |
| NO980603D0 (no) | Fremgangsmåte og anordning for komplettering av en underjordisk brönn | |
| NO980602D0 (no) | Fremgangsmåte og anordning for komplettering av en underjordisk brönn | |
| NO980591D0 (no) | Fremgangsmåte og anordning for komplettering av en underjordisk brönn | |
| NO983278L (no) | System for inspeksjon og evaluering av utstyr, system for administrering av | |
| NO973266D0 (no) | Anordning for komplettering av en underjordisk brönn og tilhörende fremgangsmåte | |
| EE200000480A (et) | Seade ja meetod manustamise toimumise indikatsiooniks | |
| NO984753L (no) | FremgangsmÕte for mÕling og system omfattende en halvstiv forlengelse | |
| FI981133A0 (fi) | Mittausmenetelmä ja -järjestelmä | |
| IT1285935B1 (it) | Metodo e dispositivo per il controllo dell'integrita' esteriore di sigarette | |
| NO330986B1 (no) | Fremgangsmate for bestemmelse av seismisk polaranisotropi | |
| NO995324L (no) | Baerer for gjenstander og emne for denne | |
| NO953527L (no) | Petrofysisk måleanordning og fremgangsmåte for bruk av denne | |
| ID27483A (id) | Metoda terapi gen | |
| FI980724L (fi) | Aikaeron mittausmenetelmä ja radiojärjestelmä | |
| NO995348D0 (no) | Glideskjötsammenstilling, og fremgangsmåte for bruk av denne | |
| NO991577D0 (no) | FremgangsmÕte og system for testing av borehull | |
| NO982074D0 (no) | FremgangsmÕte og instrument for nivÕmÕling | |
| FI981029A0 (fi) | Menetelmä ja järjestely testaukseen | |
| FI981431A7 (fi) | Mittausmenetelmä | |
| NO995159D0 (no) | Fremgangsmåte og anordning for fremstilling av asfalt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |